HIV infection in the United States has been fundamentally transformed by antiretroviral therapy. Viral suppression is now achievable for most patients, and sustained undetectable viral load eliminates sexual transmission. The clinical challenge has shifted accordingly: adults 65 and older are now the fastest-growing HIV-positive population in the country, with prevalence in that group rising 40% between 2015 and 2019. In this population, cardiovascular disease and cancer have surpassed AIDS-defining illness as the primary drivers of mortality. Polypharmacy is nearly universal, with older patients averaging 13 daily medications — the majority unrelated to HIV.
AAVBC's HIV/AIDS Quick Reference Guide provides primary care clinicians with a structured reference for managing HIV as a chronic condition across the lifespan. Covering universal screening protocols, B20 and Z21 coding distinctions, antiretroviral therapy documentation, comorbidity screening, drug interaction management, and MEAT documentation standards, the guide is grounded in current DHHS and IAS-USA evidence and oriented toward the longitudinal primary care role that modern HIV management requires.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of HIV/AIDS — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
HIV infection in the United States has been fundamentally transformed by antiretroviral therapy. Viral suppression is now achievable for most patients, and sustained undetectable viral load eliminates sexual transmission. The clinical challenge has shifted accordingly: adults 65 and older are now the fastest-growing HIV-positive population in the country, with prevalence in that group rising 40% between 2015 and 2019. In this population, cardiovascular disease and cancer have surpassed AIDS-defining illness as the primary drivers of mortality. Polypharmacy is nearly universal, with older patients averaging 13 daily medications — the majority unrelated to HIV.
AAVBC's HIV/AIDS Quick Reference Guide provides primary care clinicians with a structured reference for managing HIV as a chronic condition across the lifespan. Covering universal screening protocols, B20 and Z21 coding distinctions, antiretroviral therapy documentation, comorbidity screening, drug interaction management, and MEAT documentation standards, the guide is grounded in current DHHS and IAS-USA evidence and oriented toward the longitudinal primary care role that modern HIV management requires.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of HIV/AIDS — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
